Predictors of clinical SYNTAX score in coronary artery disease: Serum uric acid, smoking, and framingham risk stratification

Journal of Invasive Cardiology

Volumn 23, Issue 12, 2011, Pages 501-504

  Xiong, Zhaojun ^a   Zhu, Cansheng ^a   Qian, Xiaoxian ^a   Zhu, Jieming ^a   Wu, Zhen ^a   Chen, Lin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

clinical SYNTAX score; coronary angiography; serum uric acid

Indexed keywords

CREATININE; URIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; CORONARY RISK; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEART EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYNTAX SCORE; URIC ACID BLOOD LEVEL;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SURVIVAL RATE; URIC ACID;

EID: 82955219545     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-234. (Pubitemid 28350165)
2. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac Imaging, council on clinical cardiology. Circulation. 2006;114(16):1761-1791. (Pubitemid 44607126)
3. Kaya EB, Yorgun H, Canpolat U, et al. Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. Atherosclerosis. 2010;213(1):178-183.
4. Bamberg F, Dannemann N, Shapiro MD, et al. Association between cardiovascular risk profiles and the presence and extent of different types of coronary atherosclerotic plaque as detected by multidetector computed tomography. Arterioscler Thromb Vasc Biol. 2008;28(3):568-574.
5. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62(2):170-180.
6. Spoon DB, Lerman A, Rule AD, et al. The association of serum uric acid levels with outcomes following percutaneous coronary intervention. J Interv Cardiol. 2010;23(3):277-283.
7. Serruys P, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. Eurointervention. 2009;5(1):50-56.
8. SYNTAX Working Group. SYNTAX score calculator. Available at: http://www.syntaxscore.com. Accessed November 2009.
9. Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol. 2007;99(8):1072-1081. (Pubitemid 46562516)
10. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.
11. Garg S, Sarno G, Garcia-Garcia HM, et al. A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score. Circ Cardiovasc Interv. 2010;3(4):317-326.
12. Levey AS, Beto JA, Coronado BE, et al. National Kidney Foundation Task Force on Cardiovascular Disease. Controlling the epidemic of cardiovascular disease in chronic renal disease. What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis. 1998;32(5):853-906. (Pubitemid 28516321)
13. Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol. 2003;41(4 Suppl S):7S-14S. (Pubitemid 36223341)
14. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106(2):221-226. (Pubitemid 34761303)
15. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287-1293. (Pubitemid 36706079)
16. Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest. 2010;120(6):1939-1949.
17. Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood. 1997;89(2):577-582. (Pubitemid 27051694)
18. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87(12):1411-1414. (Pubitemid 32523032)
19. Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric aid to longitudinal blood pressure tracking and hypertension incidence in the Framingham Heart Study. Hypertension. 2005;45(1):28-33. (Pubitemid 40066409)
20. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009;114(4):300-305.
21. Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27(10):1174-1181.
22. Pacifico L, Cantisani V, Anania C, et al. Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children. Eur J Endocrinol. 2009;160(1):45-52.
23. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 2000;283(18):2404-2410. (Pubitemid 30257539)
24. Meisinger C, Koenig W, Baumert J, Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008;28(6):1186-1192.
25. Gur M, Yilmaz R, Demirbag R, Aksoy N. Relation of serum uric acid levels with the presence and severity of angiographic coronary artery disease. Angiology. 2008;59(2):166-171. (Pubitemid 351521110)
26. Kaya EB, Yorgun H, Canpolat U, et al. Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. Atherosclerosis. 2010;213(1):178-183.
27. Brand FN, McGee DL, Kannel WB, Stokes J 3rd, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol. 1985;121(1):11-18. (Pubitemid 15150683)
28. Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart. 1997;78(2):147-153. (Pubitemid 27404949)
29. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053- 3061.